Forendo Pharma
Turku
About Forendo Pharma
Forendo Pharma is a developer of novel drugs intended for the treatment of urological and other endocrinological diseases. The company's drugs are competent in tissue-specific hormone mechanisms for the treatment of broader gynecological conditions and Fispemifene, a novel SERM, enabling medical companies to improve the treatment of male urological conditions and giving new opportunities to unmet needs in women's and men's health.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $30.7M
- Funding stage: M&A
- Last round: Series Unknown (Jul 2019)
- Website: forendo.com
- Phone: (358) 403-1080
Industries & Categories
Health Care, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/forendo-pharma-121358 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.